Global Virus Filtration Market Size
The virus filtration market comprises products such as kits, reagents, and
systems that are used for removing viruses from biologicalTherapeutics like
vaccines and gene therapies require stringent purification processes to remove
viruses and ensure patient safety. Virus filtration helps purify biotherapeutic
products and remove viral impurities. This purification process is crucial as
live viruses could multiply in patients, potentially resulting in new diseases.
The global
Virus Filtration Market is estimated to be valued at US$ 5.86 Bn in 2024 and is
expected to exhibit a CAGR of 3.1% over the forecast period 2024 to 2031, as
highlighted in a new report published by Coherent Market Insights.
Market key trends:
Rapid adoption of virus filtration in the biopharmaceutical industry has been a
key trend fueling the market growth. Virus filtration is increasingly being
used downstream and upstream in bioproduction processes to remove viruses.
Several biopharma companies have enhanced their virus clearance capabilities
using virus filtration for products such as gene therapies, vaccines, and blood
plasma derivatives. Growing demand for biotherapeutics and stringent
regulations regarding viral safety has prompted biomanufacturers to invest in
virus filtration technologies. This has propelled the virus filtration market
growth over the recent past.
Segment Analysis
The global virus filtration market is dominated by the pharmaceutical and
biotechnology segment. This segment accounted for the largest market share in
2023 owing to the widespread application of virus filtration in manufacturing
biologicals and therapeutics such as vaccines, blood and blood products, and
stem cell products. Virus filtration ensures the safety and quality of
biotherapeutics and removal of viruses that may contaminate cell culture
processes and products used for treatment and prevention of diseases.
Key Takeaways
Global
Virus Filtration Market Size is expected to witness high growth over
the forecast period. The growth can be attributed to increasing demand for
biotherapeutics across regions and stringent regulatory requirements for purity
and safety of biologics. The global Virus Filtration Market is estimated to be
valued at US$ 5.86 Bn in 2024 and is expected to exhibit a CAGR of 3.1% over the
forecast period 2024 to 2031.
Regional analysis: North America dominated the global market and was valued at
US$ 2.09 Mn in 2024 owing to well-established biopharmaceutical industry in the
region and stringent regulatory environment mandating virus clearance in
production processes. Asia Pacific is expected to witness the fastest growth
over the forecast period due to expanding biotech sector, growing biosimilars
industry and rising research focus on development of novel biologics.
Key players related content: Key players operating in the virus filtration
market are Astellas Pharma, Genzyme Corporation, and Accord Healthcare Lt.
The global market is highly competitive with major players focusing on new
product launches, expansion of manufacturing facilities and collaboration with
research institutes for development of innovative virus filtration
technologies. For instance, in 2022, Sartorius Stedim Biotech acquired selected
life science businesses of Novasep to strengthen its filtration product
portfolio.
Explore More Related Article On This
Topic: https://www.ukwebwire.com/virus-filtration-market-size/
Explore More Related Article: https://techaxen.com/mesenchymal-stem-cells-the-future-of-regenerative-medicine/